NCT04692506View on ClinicalTrials.gov

Study Evaluating the Safety and Tolerability

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 5, 2021

Primary Completion Date

February 24, 2021

Study Completion Date

February 24, 2021

Conditions
Healthy Volunteers
Interventions
OTHER

Probiotic

The study product is probiotic

Trial Locations (1)

75237

CTC, Dag Hammarskjölds väg 10B, Uppsala

Sponsors

Lead Sponsor

BioGaia AB
All Listed Sponsors
lead

BioGaia AB

INDUSTRY

NCT04692506 - Study Evaluating the Safety and Tolerability | Biotech Hunter | Biotech Hunter